Literature DB >> 2477252

Only dull CD3+ thymocytes bind to thymic epithelial cells. The binding is elicited by both CD2/LFA-3 and LFA-1/ICAM-1 interactions.

S Nonoyama1, M Nakayama, T Shiohara, J Yata.   

Abstract

In view of the necessity for thymocytes to interact with thymic epithelial cells to differentiate into mature T cells, this study analyzed the binding between human thymocytes, cultured thymic epithelial cells (CTEC) and the required adhesion molecules. Immediately after separation, thymic epithelial cells (TEC) readily expressed ICAM-1, which is one of the ligands of LFA-1 cell adhesion molecules. However, the ICAM-1 expression was gradually lost upon culture of TEC. IFN-gamma re-induced ICAM-1 on the CTEC, and the ability of CTEC to bind to thymocytes was also increased by IFN-gamma treatment. The increase in binding seemed to be caused by the LFA-1/ICAM-1 interaction, since it was inhibited by anti-ICAM-1 monoclonal antibody (mAb) and anti-LFA-1 mAb. This suggests that the LFA-1/ICAM-1 interaction is also involved in vivo with the binding of thymocytes to TEC, which have been shown to express ICAM-1. To better understand the nature of the cells involved in binding, thymocytes were sorted into CD3-, CD3dull+, and CD3bright+ subsets (which are supposed to represent the immature, intermediate and mature stages of differentiation, respectively), and were examined for their binding to IFN-gamma-treated CTEC. The result showed that only the CD3dull+ subset bound to CTEC. CD3-, CD3bright+ cells and peripheral blood T lymphocytes did not bind, but they were induced to bind by neuramidase treatment All these bindings were inhibited by anti-LFA-1 mAb and anti-CD2 mAb. These findings indicate that CD3dull+ cells can bind to TEC via CD2/LFA-3 and LFA-1/ICAM-1 interactions. Other cells seemed not to bind to TEC because of sialylation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2477252     DOI: 10.1002/eji.1830190917

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  7 in total

1.  Defective signal transduction by the CD2 molecule in immature T-cell receptor/CD3- thymocytes.

Authors:  L A Turka; M C Fletcher; N Craighead; C B Thompson; C H June
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-15       Impact factor: 11.205

2.  T cell differentiation in the thymus.

Authors:  C E Grossi; A Favre; M Giunta; G Corte
Journal:  Cytotechnology       Date:  1991-02       Impact factor: 2.058

3.  Treatment with anti-LFA-1 alpha monoclonal antibody selectively interferes with the maturation of CD4- 8+ thymocytes.

Authors:  C Revilla; A L González; C Conde; M López-Hoyos; J Merino
Journal:  Immunology       Date:  1997-04       Impact factor: 7.397

4.  Tissue distribution of very late activation antigens-1/6 and very late activation antigen ligands in the normal thymus and in thymoma.

Authors:  L P Ruco; P Paradiso; M Pittiglio; M G Diodoro; A J Gearing; F Mainiero; A Gismondi; A Santoni; C D Baroni
Journal:  Am J Pathol       Date:  1993-03       Impact factor: 4.307

5.  Adhesion molecules involved in the binding and subsequent engulfment of thymocytes by a rat thymic epithelial cell line.

Authors:  M Colić; D Vucević; M Miyasaka; T Tamatani; M D Pavlović; A Dujić
Journal:  Immunology       Date:  1994-11       Impact factor: 7.397

6.  A novel integrin involved in thymocyte-thymic epithelial cell interactions.

Authors:  M Giunta; A Favre; D Ramarli; C E Grossi; G Corte
Journal:  J Exp Med       Date:  1991-06-01       Impact factor: 14.307

7.  Early human T cell development: analysis of the human thymus at the time of initial entry of hematopoietic stem cells into the fetal thymic microenvironment.

Authors:  B F Haynes; C S Heinly
Journal:  J Exp Med       Date:  1995-04-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.